awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39227773-19935AA6-F0C0-4D34-8434-F51AB04AA07C
Q39227773-19935AA6-F0C0-4D34-8434-F51AB04AA07C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39227773-19935AA6-F0C0-4D34-8434-F51AB04AA07C
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
P2860
Q39227773-19935AA6-F0C0-4D34-8434-F51AB04AA07C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39227773-19935AA6-F0C0-4D34-8434-F51AB04AA07C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ab2c172389bd6c6d4bec976bb6cd209cdf5eca4
P2860
Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma